Results 21 to 30 of about 19,566 (247)

Preclinical efficacy of [V 4 Q 5 ]dDAVP, a second generation vasopressin analog, on metastatic spread and tumor-associated angiogenesis in colorectal cancer [PDF]

open access: yes, 2018
Purpose Control of metastatic spread of colorectal cancer (CRC) remains as a major therapeutic challenge. [V 4 Q 5 ]dDAVP is a vasopressin peptide analog with previously reported anticancer activity against carcinoma tumors.
Alonso, Daniel Fernando   +6 more
core   +1 more source

Diagnosis of von Willebrand disease in Argentina: a single institution experience [PDF]

open access: yes, 2017
von Willebrand disease (VWD) is the most common autosomal bleeding disorder, mostlyinherited as dominant trait. VWD is due to deficiency/abnormality of von Willebrand factor (VWF).
Blanco, Alicia Noemi   +5 more
core   +1 more source

Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis [PDF]

open access: yes, 2016
Most patients with monosymptomatic nocturnal enuresis can be effectively treated with an enuresis alarm or antidiuretic therapy (desmopressin), depending on the pathophysiology of the condition in the individual patient.
Kamperis, Konstantinos   +3 more
core   +2 more sources

Von Willebrand Disease [PDF]

open access: yes, 2017
Von Willebrand Disease (VWD) is a blood clotting disorder characterized by low levels of the Von Willebrand Factor (VWF) in the blood. VWF is functions to bind platelets and promote clotting of the blood when vascular injury occurs.
Misla David, Ramon
core   +2 more sources

Use of Desmopressin in Hyponatremia: Foe and Friend

open access: yesKidney Medicine, 2019
Use of desmopressin (1-deamino-8-d-arginine vasopressin; DDAVP), a synthetic vasopressin receptor agonist, has expanded in recent years. Desmopressin leads to renal water retention, and iatrogenic hyponatremia may result if fluid intake is not ...
Steven G. Achinger, Juan Carlos Ayus
doaj   +1 more source

Systematic review and meta-analysis of randomized control trials addressing efficacy and safety of desmopressin for females with nocturia

open access: yesContinence, 2023
Aim:: To conduct a systematic review and meta-analysis of all randomized placebo-controlled trials (RCTs) that evaluated the efficacy and safety of desmopressin versus placebo among females with nocturia. Methods:: PubMed, Scopus, Web of Science, CENTRAL,
Jawaher A. Alsahabi   +5 more
doaj   +1 more source

Nasal Drug Delivery Systems: An Overview [PDF]

open access: yes, 2015
Since ancient times, drugs have been administered via the nasal route for therapeutic and recreational purposes. The interest in, and importance, of the systemic effects of drugs administered through the nasal route, have expanded over recent decades ...
Conway, Barbara R.   +3 more
core   +1 more source

Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study

open access: yesAnnals of Intensive Care, 2019
Background In traumatic brain injury (TBI) patients desmopressin administration may induce rapid decreases in serum sodium and increase intracranial pressure (ICP).
A. Harrois   +19 more
doaj   +1 more source

Short Term Effect and Safety of Antidiuretic Hormone in the Patients with Nocturia [PDF]

open access: yesInternational Neurourology Journal, 2010
Purpose To investigate the short-term safety of antidiuretic hormone in elderly patients with nocturnal polyuria, focus on hyponatremia and others electrolytes disturbances and to assess short-term effects on nocturnal urine output and number of ...
Dong Il Kang   +5 more
doaj   +1 more source

Spontaneous bleeding in a patient with malignant lymphoma: A case of acquired hemophilia [PDF]

open access: yes, 2000
Background: Acquired hemophilia is a rare condition which can be associated with lymphoproliferative disease. Case Report: Eleven yea rs after the diagnosis of immunocytoma had been made, a 72-year-old man developed a high-titer factor VIII inhibitor. At
Brack, N.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy